ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,114.63
      -0.01%
      US Tech 100
      21,524.40
      0.41%
      Dow Jones
      44,546.08
      -0.37%
      Brent Oil
      74.735
      0.67%
      Bitcoin
      95,935.98
      -0.20%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sonnet BioTherapeutics Holdings Inc (SONN) Quote

      Sonnet BioTherapeutics Holdings Inc

      Sonnet BioTherapeutics Holdings Inc (SONN)

      NASDAQ
      1.59
      0.05
      (3.25%)
      Closed February 17 4:00PM
      Delayed by 15 minutes
      1.5997
      0.0097
      (0.61%)
      After Hours: 7:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.5997
      Bid
      1.56
      Ask
      1.60
      Volume
      42,232
      1.54 Day's Range 1.5999
      1.41 52 Week Range 18.7192
      Market Cap
      4.904M
      Previous Close
      1.54
      Open
      1.55
      Last Trade
      2
      @
      1.5513
      Last Trade Time
      Financial Volume
      $ 66,354
      VWAP
      1.5712
      Average Volume (3m)
      1,135,446
      Shares Outstanding
      3,065,701
      Dividend Yield
      -
      PE Ratio
      -0.64
      Earnings Per Share (EPS)
      -2.43
      Revenue
      19k
      Net Profit
      -7.44M

      About Sonnet BioTherapeutics Holdings Inc

      Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Management Consulting Svcs
      Website
      www.sonnetbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2020
      Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was $1.54. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of $ 1.41 to $ 18.7192.

      Sonnet BioTherapeutics currently has 3,065,701 shares outstanding. The market capitalization of Sonnet BioTherapeutics is $4.72 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.64.

      Ask ADVFN Intelligence (AI)

      SONN Latest News

      More News

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      February 13 2025
      SONN (3.25%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 13 2025
      SONN (3.25%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      February 03 2025
      SONN (3.25%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      February 03 2025
      SONN (3.25%)

      Form 424B3 - Prospectus [Rule 424(b)(3)]
      Edgar (US Regulatory)
      January 31 2025
      SONN (3.25%)

      Form 424B3 - Prospectus [Rule 424(b)(3)]
      Edgar (US Regulatory)
      January 31 2025
      SONN (3.25%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0003-0.018751.61.65671.5587191.57067965CS
      40.04973.20645161291.552.051.441613031.78382325CS
      12-1.2803-44.45486111112.884.851.4111354461.94849294CS
      26-4.0403-71.63652482275.6410.021.417685022.76160408CS
      52-10.4803-86.757450331112.0818.71921.414256553.7072835CS
      156-729.4691-99.7811833852731.06881649.40161.411897775550.10815282CS
      260-15324.4803-99.989562236415326.0839916.81.4122678892543.64668199CS

      SONN - Frequently Asked Questions (FAQ)

      What is the current Sonnet BioTherapeutics share price?
      The current share price of Sonnet BioTherapeutics is $ 1.5997
      How many Sonnet BioTherapeutics shares are in issue?
      Sonnet BioTherapeutics has 3,065,701 shares in issue
      What is the market cap of Sonnet BioTherapeutics?
      The market capitalisation of Sonnet BioTherapeutics is USD 4.72M
      What is the 1 year trading range for Sonnet BioTherapeutics share price?
      Sonnet BioTherapeutics has traded in the range of $ 1.41 to $ 18.7192 during the past year
      What is the PE ratio of Sonnet BioTherapeutics?
      The price to earnings ratio of Sonnet BioTherapeutics is -0.64
      What is the cash to sales ratio of Sonnet BioTherapeutics?
      The cash to sales ratio of Sonnet BioTherapeutics is 250
      What is the reporting currency for Sonnet BioTherapeutics?
      Sonnet BioTherapeutics reports financial results in USD
      What is the latest annual turnover for Sonnet BioTherapeutics?
      The latest annual turnover of Sonnet BioTherapeutics is USD 19k
      What is the latest annual profit for Sonnet BioTherapeutics?
      The latest annual profit of Sonnet BioTherapeutics is USD -7.44M
      What is the registered address of Sonnet BioTherapeutics?
      The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Sonnet BioTherapeutics website address?
      The website address for Sonnet BioTherapeutics is www.sonnetbio.com
      Which industry sector does Sonnet BioTherapeutics operate in?
      Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      JTAIJet AI Inc
      $ 6.02
      (133.33%)
      		101.64M
      SRMSRM Entertainment Inc
      $ 0.6999
      (95.50%)
      		248.48M
      WRDWeRide Inc
      $ 31.4877
      (83.39%)
      		20.57M
      INLFINLIF Limited
      $ 16.27
      (80.58%)
      		7.67M
      MBRXMoleculin Biotech Inc
      $ 2.1201
      (66.94%)
      		134.88M
      BLACBellevue Life Sciences Acquisition Corporation
      $ 3.08
      (-56.31%)
      		430.77k
      BLACUBellevue Life Sciences Acquisition Corporation
      $ 3.36
      (-52.68%)
      		5.21k
      CSAICloudastructure Inc
      $ 19.0001
      (-49.58%)
      		1.03M
      NEXNNexxen International Ltd
      $ 10.30
      (-49.16%)
      		164.82k
      BSLKBolt Projects Holdings Inc
      $ 0.6626
      (-46.13%)
      		13.4M
      CNSPCNS Pharmaceuticals Inc
      $ 0.1415
      (31.26%)
      		489.28M
      MGOLMGO Global Inc
      $ 0.7176
      (-15.08%)
      		417.31M
      SRMSRM Entertainment Inc
      $ 0.6999
      (95.50%)
      		254.39M
      INTCIntel Corporation
      $ 23.60
      (-2.20%)
      		230.26M
      NVDANVIDIA Corporation
      $ 138.85
      (2.63%)
      		194.99M

      SONN Discussion

      View Posts
      tw0122 tw0122 2 months ago
      Cash out time 5.45 + 150%
      👍 1
      LowFloatLopes LowFloatLopes 2 months ago
      I'm at $2.50 out at $4.50 in less than 8 mins lol 
      👍️0
      tw0122 tw0122 2 months ago
      Don't stay in long this one hardly ever stays up high long 3.49 +'80%
      👍️0
      Monksdream Monksdream 2 months ago
      SONN, 10Q due DEC 13
      👍️0
      tw0122 tw0122 3 months ago
      Reverse split was September 
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
      👍️0
      Tiger Money Tiger Money 3 months ago
      What is going on here?  Reverse?  Where is the float on this train wreck now?
      👍️0
      bigfart bigfart 3 months ago
      So insiders can dump before the RS
      👍️0
      tw0122 tw0122 3 months ago
      Reverse split offering and now some news $8s
      👍️0
      tw0122 tw0122 5 months ago
      May the reverse split gods come soon. Keep an eye!
      👍️0
      BooDog BooDog 5 months ago
      Another split here too.

      https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
      👍️0
      Clemdane Clemdane 5 months ago
      Big jump today!
      👍️0
      Awl416 Awl416 6 months ago
      Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
      👍️ 1
      Monksdream Monksdream 6 months ago
      SONN new 52=low
      👍️0
      Clemdane Clemdane 6 months ago
      Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
      👍️0
      Monksdream Monksdream 6 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      SONN new 52 week low
      👍️0
      BooDog BooDog 10 months ago
      I see 76 followers here. And I have a target price of around 1.50 for support.

      GL.

      I do own shares and am looking for this to have a good future.
      👍️0
      maq1214 maq1214 11 months ago
      Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
      👍️0
      81vette 81vette 11 months ago
      23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
      👍️0
      81vette 81vette 11 months ago
      They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
      👍️0
      maq1214 maq1214 11 months ago
      Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
      👍️0
      81vette 81vette 11 months ago
      $2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
      👍️0
      81vette 81vette 11 months ago
      254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
      👍️0
      81vette 81vette 11 months ago
      5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
      👍️0
      BooDog BooDog 11 months ago
      Riding free again.
      👍️0
      Monksdream Monksdream 12 months ago
      SONN under $2
      👍️0
      crowin crowin 1 year ago
      Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
      👍️0
      maq1214 maq1214 1 year ago
      This should get exciting soon, crazy volume yesterday !
      👍️0
      BooDog BooDog 1 year ago
      IS it just greed or might this make good for another round trip? We'll see next week.
      👍️0
      BooDog BooDog 1 year ago
      Good move IMO. Surprising actually.

      On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

      https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      BooDog BooDog 1 year ago
      Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

      https://www.accesswire.com/viewarticle.aspx?id=796208
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
      👍️0
      Monksdream Monksdream 1 year ago
      If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      You worry about you ok?
      👍️0
      Monksdream Monksdream 1 year ago
      You aren’t getting any money back
      Time to move on
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      Not an Urban Myth ..I've already checked. They have current D and O insurance.
      👍️0
      Monksdream Monksdream 1 year ago
      Oh goddamn tell me another urban myth
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
      👍️0
      Monksdream Monksdream 1 year ago
      You wouldn’t get anything from a class action lawsuit
      Anyone connected to professional asset management abandoned this company long ago
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0

      Your Recent History

      NASDAQ
      SONN
      Sonnet BioTherapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads